Submissions from 2025
Elevated creatinine-to-hemoglobin ratio is a novel preoperative marker for worsened survival outcomes in upper tract urothelial carcinoma: analysis from the ROBUUST registry., Margaret F Meagher, Clara Cerrato, Mimi V Nguyen, Riccardo Autorino, Reza Mehrazin, Daniel Eun, Vitaly Margulis, Robert Uzzo, James R Porter, Chandru Sundaram, Firas Abdollah, Alexandre Mottrie, Andrea Minervini, Alessandro Antonelli, Maria A Cerruto, Matteo Ferro, Hooman Djaladat, Zhenjie Wu, Alireza Ghoreifi, Kevin Hakimi, Cesare Saitta, Ava Saidian, Arman Walia, Savio D Pandolfo, Riccardo Tellini, Alessandro Veccia, Elio Mazzone, Koon Rha, Mark Gonzalgo, and Ithaar H Derweesh
Phase 2 Study of Zilovertamab Vedotin in Participants with Metastatic Solid Tumors., Funda Meric-Bernstam, Martin Gutierrez, Enrique Sanz-Garcia, Diego Villa, Jun Zhang, Jennifer Friedmann, Fengting Yan, Mark A Socinski, John Sarantopoulos, Luis E Raez, Quincy S Chu, Maxime Chénard-Poirier, Manash S Chatterjee, Hong Ren, Qi Liu, Douglas A Levine, and Komal L Jhaveri
Phase 1b/2 study evaluating safety, efficacy and immune effects of TLR9 agonist cavrotolimod with anti-PD-1 antibodies among patients with advanced solid tumors., Mohammed M Milhem, Trisha M Wise-Draper, Sunandana Chandra, Glenn J Hanna, Douglas E Laux, Theresa M Medina, George Ansstas, Adil Daud, Ciara M Kelly, Steven J O'Day, Cesar A Perez, Michael K Wong, Philip A Friedlander, Timothy S Kristedja, Melissa A Burgess, C Lance Cowey, Brent A Hanks, Ryan M Weight, Weston L Daniel, Douglas E Feltner, Scott Mix, Laurel Sindelar, Alice S Bexon, Martin F Bexon, Robert E Michel, and Shailender Bhatia
A fibroblast-centric network drives cold fibrosis in the tumor microenvironment of lung squamous cell carcinoma., Shoval Miyara, Shachaf Frenkel, Avi Mayo, Philippe Gascard, Michael Strasser, David Gibbs, Eviatar Weizman, Itay Ben Shalom, Yaniv Stein, Deng Pan, Joseph A Caruso, Veena Sangwan, Nicholas Bertos, Julie Berube, Sophie Camilleri-Broet, Spyridon Oikonomopoulos, Haig Djambazian, Kfir Baruch Umansky, Jacob Elkahal, Shimrit Mayer, Pierre-Olivier Fiset, Jiannis Ragoussis, Miri Adler, Eldad Tzahor, Sui Huang, Lorenzo Ferri, Thea D Tlsty, Ruth Scherz-Shouval, and Uri Alon
Characterization of pritumumab in murine models and primate safety study., Avani A Mody, Rajesh Mukthavaram, Pengfei Jiang, Kishore Gangangari, Nagavarakishore Pillarsetty, Pranav R Kesari, Vijay Padul, Sneha L Kesari, Elnaz Rahbarlayegh, Mark C Glassy, and Santosh Kesari
Patterns of Clinical Trial Enrollment for Pediatric Patients With Hepatoblastoma and Wilms Tumor: A Report From the Children's Oncology Group., Pablo S Monterroso, Sarah Lucht, Jeannette M Sample, Angela D Trobaugh-Lotrario, Helen M Parsons, Lucie M Turcotte, David Van Riper, Jenny N Poynter, and Erin L Marcotte
An Atypical Presentation of Metastatic Gastric Adenocarcinoma Due to Pulmonary Lymphangitic Carcinomatosis, Matthew Moritz, MD and Omar Pandhair, MD
Long-Term Outcomes of Radiation Monotherapy Versus Combined Radiation Monotherapy + Hormone Therapy in Low-Risk Early-Stage Breast Cancer Patients 70 Years or Older After Breast-Conserving Surgery., Astrid D Morris, Douglas Hanes, and Henry G Kaplan
Proceedings of the National Cancer Institute Workshop on combining immunotherapy with radiotherapy: challenges and opportunities for clinical translation., Zachary S Morris, Sandra Demaria, Arta M Monjazeb, Silvia C Formenti, Ralph R Weichselbaum, James Welsh, Heiko Enderling, Jonathan D Schoenfeld, Joshua D Brody, Heather M McGee, Michele Mondini, Michael S Kent, Kristina H Young, Lorenzo Galluzzi, Sana D Karam, Willemijn S M E Theelen, Joe Y Chang, Mai Anh Huynh, Adi Daib, Sean Pitroda, Caroline Chung, Raphael Serre, Clemens Grassberger, Jie Deng, Quaovi H Sodji, Anthony T Nguyen, Ravi B Patel, Simone Krebs, Anusha Kalbasi, Caroline Kerr, Claire Vanpouille-Box, Logan Vick, Todd A Aguilera, Irene M Ong, Fernanda Herrera, Hari Menon, DeeDee Smart, Jalal Ahmed, Robyn D Gartrell, Christina L Roland, Fatemeh Fekrmandi, Binita Chakraborty, Eric H Bent, Tracy J Berg, Alan Hutson, Samir Khleif, Andrew G Sikora, and Lawrence Fong
Team-Based Versus Technology-Based Supportive Cancer Care: A Mixed Methods Study of Multi-Site Implementation., Sacha Moufarrej, Emily H Wood, Niharika Dixit, Raymond Liu, Lori Sakoda, Finly Zachariah, Gabrielle Rocque, M Zachary Koontz, David J Park, Daniel Kwon, Jennifer Y Pierce, Sangeeta Aggarwal, Rebbeca Sudore, Tumaini Coker, and Manali I Patel
Ivermectin and gynecologic cancer: What's the data?, Vaidehi Mujumdar, Marilyn Huang, Lindsey Chippendale Smith, and Fernanda Musa
Individualized dynamic risk assessment and treatment selection for multiple myeloma., Carl Murie, Serdar Turkarslan, Anoop P Patel, David G Coffey, Pamela S Becker, and Nitin S Baliga
In-depth analysis of endogenous retrovirus expression in glioblastoma., Daniel A Murimi-Worstell, Irene B Murimi-Worstell, Farrah M Roy, Aidan Burn, Michael Freeman, Ralph B Puchalski, and John M Coffin
State of the art endocrine treatments for patients diagnosed with endometrial cancer in 2025., Fernanda Musa, Kathleen N Moore, Vivek Podder, and Brian M Slomovitz
Multiomic Characterization of, Misako Nagasaka, Brian Warnecke, Sai-Hong Ignatius Ou, Sahar F Bannoura, Chul Kim, Andrew Elliott, Balazs Halmos, Dave Hoon, Sourat Darabi, Ammar Sukari, Milan Radovich, Emil Lou, George Sledge, Wafik El-Deiry, Mohammed Najeeb Al-Hallak, Boris C Pasche, and Asfar S Azmi
Ubiquitin E3 ligase KPC1 governs mesenchymal metastatic melanoma reprogramming via proteasomal degradation of ZEB1., Yusuke Nakano, Matias A Bustos, Kelly Chong, Yoshinori Hayashi, Aaron Ciechanover, and Dave S B Hoon
Integrated Antigenic and Nucleic Acid Detection in Single Virions and Extracellular Vesicles with Viral Content., Kim Truc Nguyen, Xilal Y Rima, Luong T H Nguyen, Xinyu Wang, Kwang Joo Kwak, Min Jin Yoon, Hong Li, Chi-Ling Chiang, Jacob Doon-Ralls, Kelsey Scherler, Shannon Fallen, Stephanie L Godfrey, Julie A Wallick, Setty M Magaña, Andre F Palmer, Inyoul Lee, Christopher C. Nunn, Kimberly M Reeves, Henry G Kaplan, Jason D Goldman, James R Heath, Kai Wang, Preeti Pancholi, L James Lee, and Eduardo Reátegui
Accuracy of Falls Screening Tools in Adult Patients With Cancer: A Systematic Review., Kelli A Nielsen, Michael Foley, Earllaine Croarkin, Patricia Runde, Stephanie Prinster, and Laura S Gilchrist
Comparative microRNA signatures based on liquid biopsy to identify lymph node metastasis in T1 colorectal cancer patients undergoing upfront surgery or endoscopic resection., Kazuaki Okamoto, Hiroaki Nozawa, Tsuyoshi Ozawa, Yoko Yamamoto, Yuichiro Yokoyama, Shigenobu Emoto, Koji Murono, Kazuhito Sasaki, Mitsuhiro Fujishiro, and Soichiro Ishihara
Genomic determinants of therapy response in ETV6::RUNX1 leukemia., Laura Oksa, Sanni Moisio, Khurram Maqbool, Roger Kramer, Atte Nikkilä, Buddika Jayasingha, Artturi Mäkinen, Hassan Foroughi-Asl, Samuli Rounioja, Janne Suhonen, Olga Krali, Miikka Voutilainen, Mari Lahnalampi, Kaisa Vepsäläinen, Sui Huang, Jesus Duque-Afonso, Julia Hauer, Jessica Nordlund, Valtteri Wirta, Olli Lohi, and Merja Heinäniemi
Use of Histotripsy to Rapidly Relieve Biliary Obstruction in a Patient With Recurrent Hilar Cholangiocarcinoma., Evan S Ong, Chase J Wehrle, and Mohamed M Alassas
Do Patients with DCIS or Invasive Breast Cancer Carry the Same Risk for Genetic Mutation?, Javier I Orozco, Betsy Valdez, Emma S Trasatti, Sandy M Brown, Kimberly K Childers, Ora K Gordon, and Janie Grumley
Chronic Marijuana Use and Chronic Obstructive Pulmonary Disease: A Case Report., Brenna Ostertag, MD and Kathryn W Hendrickson
Prognostic Impact of Adjuvant Immunotherapy in Patients with High-Risk Upper Tract Urothelial Cancer: Results from the ROBUUST 2.0 Collaborative Group., Maxwell Otiato, Farshad Sheybaee Moghaddam, Alireza Ghoreifi, Riccardo Autorino, Gabriele Bignante, Chandru Sundaram, Daniel Sidhom, Ithaar H Derweesh, Dhruv Puri, Vitaly Margulis, Benjamin Popokh, Firas Abdollah, Alex Stephens, Matteo Ferro, Giuseppe Simone, Gabriele Tuderti, Reza Mehrazin, Ahmed Eraky, Mark Gonzalgo, Omar Falik Nativ, Zhenjie Wu, Francesco Porpiglia, Enrico N Checcucci, Andres Correa, Randall Lee, Alessandro Antonelli, Alessandro Veccia, Soroush Rais-Bahrami, Alireza Dehghanmanshadi, Nirmish Singla, Stephan Brönimann, Sisto Perdonà, Roberto Contieri, Takashi Yoshida, James Porter, Saum Ghodoussipour, Luca Lambertini, Andrea Minervini, and Hooman Djaladat
Results of a phase 1/2 study of sacituzumab tirumotecan in patients with unresectable locally advanced or metastatic solid tumors refractory to standard therapies., Quchang Ouyang, Jordi Rodon, Yan Liang, Xinhong Wu, Qun Li, Lihua Song, Min Yan, Zhongsheng Tong, YunPeng Liu, Zev A Wainberg, Ying Wang, Cuizhi Geng, Susanna V Ulahannan, Guohua Yu, Manish R Sharma, Xiang Wang, Judy S Wang, Alexander Spira, Weihong Zhao, Rachel E Sanborn, Ying Cheng, Xian Wang, Gesha Liu, Yaling Li, Junyou Ge, Elliot Chartash, Omobolaji O Akala, and Yongmei Yin
Assessment of Functional Status of Human Leukocyte Antigen Class I Genes in Cancer Tissues in the Context of Personalized Neoantigen Peptide Vaccine Immunotherapy., Vijay G Padul, Nupur Biswas, Mini Gill, Jesus A Perez, Javier J Lopez, Santosh Kesari, and Shashanka Ashili
Analysis of Endoscope-Assisted Retrosigmoid Approach versus Modified Transjugular Approach for Microvascular Decompression of the Facial Nerve: A Comparative Cadaveric Study., Mehrdad Pahlevani, Felipe Sfeir, Fan Zhao, Kayla Lanker, Alex Corlin, Regin Jay Mallari, Gregory Lekovic, and Garni Barkhoudarian
The PRL3-zumab paradigm: A multicenter, single-dose-level phase 2 basket clinical trial design of an unconventional cancer immunotherapy., David J Park, Min Thura, Vi K Chiu, Brian Vicuna, Koon Hwee Ang, Blanca Sanchez, Pei Ling Chia, Kam Yew Kuan, Jie Li, Ke Zhang, Wei Hui Zheng, Matthew Chau Hsien Ng, and Qi Zeng
Interleukin-12 anchored drug conjugate (tolododekin alfa) in patients with advanced solid tumors: first-in-human Phase 1 trial., Jong Chul Park, Brendan Curti, Marcus Butler, Eric Wehrenberg-Klee, Joseph Elassal, Robert Tighe, Sailaja Battula, Gail Iodice, Howard L Kaufman, and John M Kirkwood
Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer: ASCO Guideline Update., Ko Un Park, Mark R Somerfield, Nirupama Anne, Muriel Brackstone, Alison K Conlin, Henrique Lima Couto, Lynn T Dengel, Andrea Eisen, Brittany E Harvey, Jeffrey Hawley, Janice N Kim, Nwamaka Lasebikan, Elizabeth S McDonald, Deepti Pradhan, Samantha Shams, Raymond Mailhot Vega, Alastair M Thompson, and Mylin A Torres
Safety and activity of tarlatamab in combination with a PD-L1 inhibitor as first-line maintenance therapy after chemo-immunotherapy in patients with extensive-stage small-cell lung cancer (DeLLphi-303): a multicentre, non-randomised, phase 1b study., Kelly G Paulson, Sally C M Lau, Myung-Ju Ahn, Mor Moskovitz, Michael Pogorzelski, Simon Häfliger, Amanda Parkes, Yuyang Zhang, Ali Hamidi, Corbin G Thompson, and Martin Wermke
Improved survival at the population level for patients with advanced Merkel cell carcinoma following availability of immunotherapy., Kelly G Paulson, Song Y Park, Shailender Bhatia, Daniel S Hippe, and Paul Nghiem
Evidence Based Research Review of Remote Independent Chemotherapy/Immunotherapy Verification, Katrina Perkins, Hannah Holder, and Marie St. Clair
Safety and efficacy of acalabrutinib plus bendamustine and rituximab in patients with treatment-naïve or relapsed/refractory mantle cell lymphoma: phase Ib trial., Tycel Phillips, Michael Wang, Tadeusz Robak, David Gallinson, Don Stevens, Krish Patel, Safaa Ramadan, Chuan-Chuan Wun, Wojciech Jurczak, and Stephen D Smith
Phase II trial of nilotinib in PDGFR-alpha-enriched recurrent high-grade gliomas., David Piccioni, Tiffany M Juarez, Sneha L Kesari, Lara Rose, Natsuko Nomura, and Santosh Kesari
Behavior Change in a Young Women: The Secret Lies in the Ovarian Tumor, Providence SVMC GME
Head and Neck Cancer Research Training Program Associated with Academic Success for Trainees., Aanish Puri, Andrew C Elton, Beverly R Wuertz, and Frank G Ondrey
Trastuzumab Plus Pertuzumab Versus Cetuximab Plus Irinotecan in Patients With, Kanwal Pratap Singh Raghav, Katherine A Guthrie, Benjamin Tan, Crystal S Denlinger, Marwan Fakih, Michael J Overman, N Arvind Dasari, Larry R Corum, Lee G Hicks, Mital S Patel, Benjamin T Esparaz, Syed M Kazmi, Nitya Alluri, Sarah Colby, Sepideh Gholami, Philip J Gold, E Gabriela Chiorean, Scott Kopetz, Howard S Hochster, and Philip A Philip
Multimodal evaluation of cerebrospinal fluid from breast cancer leptomeningeal metastases using circulating tumor cell detection, single-cell sequencing, and proteomics., Elnaz Rahbarlayegh, Alexandre Wojcinski, Natsuko Nomura, Tiffany Juarez, Barbara Blouw, and Santosh Kesari
Biomarker-guided dose selection in the iintune-1 study of dazostinag,a STING agonist, alone and in combination with pembrolizumab for patients with metastatic solid tumors, R Ramesh, Rachel Sanborn, and See full list of authors in comments
Adoption of Single-Port Robotic Partial Nephrectomy Increases Utilization of the Retroperitoneal Approach: A Report from the Single-Port Advanced Research Consortium., Michael Raver, Mutahar Ahmed, Kennedy E Okhawere, Indu Saini, Ruchir Chaturvedi, Milan Patel, Ruben Sauer Calvo, Nicolas A Soputro, Roxana Ramos, Mubashir Billah, Simone Crivellaro, Ahmed M Mansour, Jihad Kaouk, Nirmish Singla, James Porter, Ronney Abaza, Akshay Bhandari, Ashok K Hemal, Phillip M Pierorazio, Benjamin I Chung, Craig G Rogers, Reza Mehrazin, Ketan Badani, and Michael Stifelman
Treatment of NSCLC after chemoimmunotherapy - are we making headway?, Martin Reck, Nikolaj Frost, Solange Peters, Bernard A Fox, Roberto Ferrara, Rajkumar Savai, and Fabrice Barlesi
AAPM medical physics practice guideline 13.a: HDR brachytherapy, part B., Susan L Richardson, Arjit K Baghwala, Gil'ad N Cohen, Claire Dempsey, Bruce Libby, Christopher S Melhus, Robin A Miller, Daniel J Scanderbeg, and Samantha J Simiele
Updated Efficacy and Safety From the Phase 2 PHAROS Study of Encorafenib Plus Binimetinib in Patients With BRAF V600E-Mutant Metastatic NSCLC-A Brief Report., Gregory J Riely, Myung-Ju Ahn, Jeffrey M Clarke, Ibiayi Dagogo-Jack, Raymond Esper, Enriqueta Felip, Francesco Gelsomino, Jonathan W Goldman, Maen Hussein, Melissa Johnson, Kristen A Marrone, Daniel Morgensztern, Ernest Nadal, Marcelo V Negrao, Michael Offin, Mariano Provencio, Suresh S Ramalingam, Logan Roof, Rachel E Sanborn, Egbert F Smit, Anne Tsao, Tiziana Usari, Ann Alcasid, Keith Wilner, Svitlana Tonkovyd, Xiaosong Zhang, and Bruce E Johnson
Developing evidence-based, cost-effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities: Proceedings from a conference organised by the Pontifical Academy of Sciences and the European Academy of Cancer Sciences, held in Vatican City, May 22-23, 2025., Ulrik Ringborg, Joachim von Braun, Julio Celis, Anton Berns, Michael Baumann, Tit Albreht, Nancy Abou-Zeid, Vanderlei Bagnato, Christian Brandts, Chien-Jen Chen, Massimiliano di Pietro, Manjit Dosanjh, Thomas Dubois, Alexander Eggermont, Angelika Eggert, Ingemar Ernberg, Sara Faithfull, Johannes Förner, Stefan Fröhling, Manuel Heitor, Leroy Hood, Wei Jiang, Bengt Jönsson, Ravi Kannan, Maria Leptin, Su Li, Peter Lindgren, Douglas Lowy, Jun Ma, Alex Markham, Péter Nagy, Simon Oberst, M Iqbal Parker, Danielle Rodin, Kevin Ryan, Joachim Schüz, Richard Sullivan, Josep Tabernero, Peter Turkson, Oliver Várhelyi, Harold Varmus, Chijie Wang, Elisabete Weiderpass, and Nils Wilking
Risk Factors for COVID-19-Related Hospitalization and Death in Patients With Cancer: The National Cancer Institute COVID-19 in Cancer Patients Study (NCCAPS)., Brian I Rini, Ana F Best, Mel D Bowman, Grace E Mishkin, Andrea M Denicoff, Larry V Rubinstein, Lyndsay Harris, Ann M Geiger, Nicholas M Mark, Steven A Pergam, Jeremy L Warner, Alok A Khorana, Sacha Gnjatic, Tina W F Yen, Darla K Liles, Christine M Bestvina, Neil J Shah, Jacqueline T Norrell, Dawn L Hershman, Jennifer L Holter-Chakrabarty, Andrew S Poklepovic, Stephen J Chanock, Hari Sankaran, and Larissa A Korde
American Association of Neurological Surgeons/Congress of the Neurological Surgeons Section on Tumors Guidelines: Assessing Their Impact on Brain Tumor Clinical Practice., Faith C Robertson, Brian V Nahed, Garni Barkhoudarian, Anand Veeravagu, David Berg, Steven Kalkanis, Jeffrey J Olson, and Isabelle M Germano
Safety of Extended Pirtobrutinib Exposure in Relapsed and/or Refractory B-Cell Malignancies., Lindsey E Roeker, Catherine C Coombs, Nirav N Shah, Wojciech Jurczak, Jennifer A Woyach, Chan Y Cheah, Krish Patel, Kami Maddocks, Yucai Wang, Pier Luigi Zinzani, Talha Munir, Youngil Koh, Meghan C Thompson, Catherine E Muehlenbein, Chunxiao Wang, Richard Sizelove, Sarang Abhyankar, Safarulla Hasanabba, Donald E Tsai, Toby A Eyre, and Michael Wang
The Atypical Presentation and Delayed Timing of Anastomotic Leak in Patients Who Undergo Cytoreducation and Hyperthermic Intraperitoneal Chemotherapy., Colin J Rog, Riom Kwakman, Charlotte van Schooten, Chloe Hanson, Elizabeth J Olecki, Richard A Erali, Joy Sarkar, Erek Nelson, Matthew G K Benesch, Shalana O'Brien, Gary Mann, Joseph Skitzki, Mohamed Alassas, and Evan S Ong
The response to anti-PD-1 and anti-LAG-3 checkpoint blockade is associated with regulatory T cell reprogramming., Annah S Rolig, Xiyu Peng, Elizabeth R Sturgill, Nisha Holay, Melissa Kasiewicz, Courtney Mick, Grace Helen Mcgee, William Miller, Yoshinobu Koguchi, Johanna Kaufmann, Niranjan Yanamandra, Sue Griffin, James Smothers, Matthew Adamow, Jasme Lee, Ronglai Shen, Margaret K Callahan, and William L Redmond
Genes associated with genetic and rare lung diseases and the risk of lung cancer., Albert Rosenberger, Heike Bickeböller, David C Christiani, Neil E Caporaso, Geoffrey Liu, Stig E Bojesen, Loic Le Marchand, Demetrios Albanes, Melinda C Aldrich, Adonina Tardon, Guillermo Fernández-Tardón, Gad Rennert, John K Field, Michael P A Davies, Lambertus A Kiemeney, Philip Lazarus, Shanbeh Zienolddiny, Stephen Lam, Matthew B Schabath, Angeline S Andrew, Susanne M Arnold, Gary E Goodman, Jennifer A Doherty, Fiona Taylor, Angela Cox, Penella J Woll, Angela Risch, Mikael Johansson, Paul Brennan, Maria Teresa Landi, Sanjay S Shete, Rayjean J Hung, and Christopher I Amos
Heavily Pretreated Refractory Diffuse Large B-Cell Lymphoma Successfully Treated with Epcoritamab: Case Report., Jeremy Rosiecki, Natalie Wallace, Katelyn Kammers, Ann-Chee Cheng, Talia Wyckoff, and Steven Liu
Wildfire disruptions and cancer care: A multi-institutional study of radiotherapy treatment adherence in Northern California., R A Sabol, C J Walsh, S Densley, Y Medhat, C C Baniel, A Krishna, C T Baiyee, D Meltzer, J Boscardin, A Witztum, N Pitts, A K Paulsson, Join Y Luh, L Zalavari, S S Yom, and K Lichter
Abstract P004: Mapping the tumor-sentinel node immune migratome demonstrates a key role for CCR7+ dendritic cells in the successful response to immunoradiotherapy, Robert Saddawi-Konefka, Shawn M. Jensen, Bernard A Fox, Richard Bryan Bell, and See full list of authors in comments
The tumor-sentinel lymph node immuno-migratome reveals CCR7⁺ dendritic cells drive response to sequenced immunoradiotherapy., Robert Saddawi-Konefka, Riyam Al Msari, Shiqi Tang, Chad Philips, Sayed Sadat, Lauren M Clubb, Sarah Luna, Santiago Fassardi, Riley Jones, Ida Franiak Pietryga, Farhoud Faraji, Shiruyeh Schokrpur, Bryan S Yung, Michael M Allevato, Kelsey E Decker, Chanond A Nasamran, Daisy Chilin-Fuentes, Shawn M Jensen, Bernard A Fox, R Bryan Bell, J Silvio Gutkind, Andrew Sharabi, and Joseph A Califano
Long-Term Survival Following Chemoradiation in Locoregional Recurrent Germline, Rachael A Safyan, Keven Zhang, Smith Apisarnthanarax, Jonathan G Sham, Venu G Pillarisetty, Sita Kugel, Marianne E Dubard-Gault, Colin C Pritchard, Eric Q Konnick, Dushyant Sahani, and E Gabriela Chiorean
Should ADCs Replace Docetaxel in 2L NSCLC, Rachel Sanborn
Should ADCs Replace Docetaxel in 2L NSCLC, Rachel Sanborn
Amivantamab-Chemotherapy in Non-Small Cell Lung Cancer with EGFR Exon 20 Insertions: Impact of Treatment Crossover and Other Endpoints from the Phase III PAPILLON Study., Rachel E Sanborn, Caicun Zhou, Ke-Jing Tang, Byoung Chul Cho, Susanna Cheng, Sanjay Popat, Akira Ono, Shun Lu, Margarita Majem, Andres Aguilar, Maria Del Rosario Garcia Campelo, Hidetoshi Hayashi, Kang-Yun Lee, Se-Hoon Lee, Angelo Delmonte, Jorge Alatorre-Alexander, Gary Richardson, Victor Santos, Christophe Dooms, Joshua K Sabari, Catherine A Shu, Nicolas Girard, Aaron S Mansfield, Keunchil Park, Yichuan Xia, Archan Bhattacharya, Nasuh Buyukkaramikli, Nolen Perualila, Joris Diels, Sandip Acharya, Conor Chandler, Irina Proskorovsky, Lindsay Dearden, Honeylet Wortman-Vayn, Parthiv J Mahadevia, Roland E Knoblauch, Trishala Agrawal, Mahadi Baig, and Enriqueta Felip
Practical management of adverse events in patients receiving tarlatamab, a delta-like ligand 3-targeted bispecific T-cell engager immunotherapy, for previously treated small cell lung cancer., Jacob M Sands, Stéphane Champiat, Horst-Dieter Hummel, Kelly G Paulson, Hossein Borghaei, Jean Bustamante Alvarez, David P Carbone, Jennifer W Carlisle, Noura J Choudhury, Jeffrey M Clarke, Shirish M Gadgeel, Hiroki Izumi, Alejandro Navarro, Sally C M Lau, Philip E Lammers, Shuang Huang, Ali Hamidi, Sujoy Mukherjee, and Taofeek K Owonikoko
Society for Immunotherapy of Cancer: Standards for Reporting of Multiplex Immunohistochemistry/Immunofluorescence Assays (STORMI)., Sam Sater, Carlo Bifulco, Jaime Rodriguez-Canales, Joe Yeong, Guray Akturk, Michael Angelo, Carmen Ballesteros-Merino, Peter Bankhead, Subham Basu, Jorge M Blando, Saska Brajkovic, Marco Cassano, Benjamin J Chen, Ahmet F Coskun, Tricia R Cottrell, Carlos E De Andrea, Robin H Edwards, Colt Egelston, Logan L Engle, Marc S Ernstoff, Rong Fan, Michael Feldman, Bernard A Fox, Jerome Galon, Robyn Gartrell, Sacha Gnjatic, Benjamin F Green, James L Gulley, Anne Hellebust, Stephen Hewitt, Travis J Hollmann, Lucas A Horn, William J Howat, Clifford C Hoyt, Shawn M Jensen, Arutha Kulasinghe, Wiem Lassoued, Steven Lott, James Mansfield, Sebastian Marwitz, George Netto, David B Page, Edwin Parra, David L Rimm, Scott J Rodig, Roberto Salgado, Denis Schapiro, Kurt A Schalper, Joel C Sunshine, Michael J Surace, Alexander S Szalay, Magdalena Thurin, Jose C Villasboas, Keith Wharton, Ignacio I Wistuba, Jennifer H Yearley, Yinyin Yuan, Geroge Zaki, James Ziai, and Janis M Taube
Social determinants of health and variability in treatment for patients with early-stage non-small cell lung cancer., Molly Scannell Bryan, Xiaohan Hu, Monika A Izano, Hina Mohammed, Marianna Wicks, Thomas Brown, George Simon, Henry G Kaplan, and Anna Berry
The improved prognosis of FLT3-internal tandem duplication but not tyrosine kinase domain mutations in acute myeloid leukemia in the era of targeted therapy: a real-world study using large-scale electronic health record data, Matthew Schwede, Gladys Rodriguez, Vanessa E Kennedy, Solomon Henry, Douglas Wood, Gabriel N Mannis, Ravindra Majeti, Jonathan H Chen, Eran Bendavid, and Tian Yi Zhang
Lisocabtagene maraleucel for R/R LBCL in patients not intended for HSCT: final results of the phase 2 PILOT study., Alison Sehgal, Daanish Hoda, Peter A Riedell, Nilanjan Ghosh, Mehdi Hamadani, Gerhard C Hildebrandt, John E Godwin, Patrick M Reagan, Nina D Wagner-Johnston, James Essell, Rajneesh Nath, Scott R Solomon, Rebecca Champion, Edward Licitra, Suzanne Fanning, Neel K Gupta, Victor A Chow, Brenda Yuan, Zhi Yang, Ken Ogasawara, Jerill Thorpe, and Leo I Gordon
Pirtobrutinib monotherapy in Bruton tyrosine kinase inhibitor-intolerant patients with B-cell malignancies: results of the phase I/II BRUIN trial., Nirav N Shah, Michael Wang, Lindsey E Roeker, Krish Patel, Jennifer A Woyach, William G Wierda, Chaitra S Ujjani, Toby A Eyre, Pier Luigi Zinzani, Alvaro J Alencar, Paolo Ghia, Nicole Lamanna, Marc S Hoffmann, Manish R Patel, Ian Flinn, James N Gerson, Shuo Ma, Catherine C Coombs, Chan Y Cheah, Ewa Lech-Maranda, Bita Fakhri, Won Seog Kim, Minal A Barve, Jonathon B Cohen, Wojciech Jurczak, Talha Munir, Meghan C Thompson, Donald E Tsai, Katherine Bao, Nicholas A Cangemi, Jennifer F Kherani, Richard A Walgren, Hongmei Han, Amy S Ruppert, and Jennifer R Brown
Correction: Efficacy and safety in a 4-year follow-up of the ELEVATE-TN study comparing acalabrutinib with or without obinutuzumab versus obinutuzumab plus chlorambucil in treatment-naïve chronic lymphocytic leukemia., Jeff P Sharman, Miklos Egyed, Wojciech Jurczak, Alan Skarbnik, John M Pagel, Ian W Flinn, Manali Kamdar, Talha Munir, Renata Walewska, Gillian Corbett, Laura Maria Fogliatto, Yair Herishanu, Versha Banerji, Steven Coutre, George Follows, Patricia Walker, Karin Karlsson, Paolo Ghia, Ann Janssens, Florence Cymbalista, Jennifer A Woyach, Emmanuelle Ferrant, William G Wierda, Veerendra Munugalavadla, Ting Yu, Min Hui Wang, and John C Byrd
Acalabrutinib-obinutuzumab improves survival vs chemoimmunotherapy in treatment-naive CLL in the 6-year follow-up of ELEVATE-TN., Jeff P Sharman, Miklos Egyed, Wojciech Jurczak, Alan Skarbnik, Krish Patel, Ian W Flinn, Manali Kamdar, Talha Munir, Renata Walewska, Marie Hughes, Laura Maria Fogliatto, Yair Herishanu, Versha Banerji, George Follows, Patricia Walker, Paolo Ghia, Ann Janssens, John C Byrd, Emmanuelle Ferrant, Alessandra Ferrajoli, William G Wierda, Catherine Wangui Wachira, Batul T Suterwala, Paulo Miranda, Veerendra Munugalavadla, Chuan-Chuan Wun, and Jennifer A Woyach
Roadmap: medical physics technologies in brachytherapy., William Y Song, Michael Roumeliotis, Junghoon Lee, Aaron Fenster, Jessica Rodgers, Tiana Trumpour, Rachel M Glicksman, Alejandro Berlin, Åsa Carlsson Tedgren, Javier Vijande, Luc Beaulieu, Björn Morén, Sandra Meyers, Alexandra Rink, Yin Gao, Benjamin P Fahimian, Debarghya China, Kai Ding, Tarun K Podder, Eric N Carver, Mark J Rivard, Susan L Richardson, Milan Grkovski, Moeen Meftahi, Ulysses Gardner, Rachit Kumar, Daniel Scanderbeg, Catheryn Yashar, Issam El Naqa, Akila N Viswanathan, and Xun Jia
Single-port Robotic Retroperitoneal Partial Nephrectomy via Low Anterior Access: A Propensity-matched Comparative Analysis to Standard Transperitoneal Multiport Robotic Surgery from the Single Port Advanced Research Consortium (SPARC)., Nicolas A Soputro, Sonam Saxena, Jewel Bamby, Arianna Biasatti, Francesco Aguirre, Ruben Sauer Calvo, Gabriela Nieto-Blanco, Rasheed Thompson, Kennedy E Okhawere, Graham Kupsaw, Abdulrahman Al-Bayati, Sarah Duncan, Gianna Jimenez, Dattatraya Patil, Shamsunnahar Imtiaz, C Adam Lorentz, Jennifer A Linehan, Simone Crivellaro, Srinivas Vourganti, Riccardo Autorino, Mihir S Shah, Andrew Wagner, Peter Chang, Mutahar Ahmed, Michael D Stifelman, Bertram Yuh, Ketan K Badani, and Jihad Kaouk
Consensus recommendations from the 2024 Lymphoma Research Foundation workshop on treatment selection and sequencing in CLL or SLL., Jacob D Soumerai, Jacqueline Barrientos, Inhye Ahn, Catherine Coombs, Douglas Gladstone, Marc Hoffman, Adam Kittai, Ryan Jacobs, Andrew Lipsky, Krish Patel, Joanna Rhodes, Alan Skarbnik, Meghan Thompson, Daniel Ermann, Patrick Reville, Harsh Shah, Jennifer R Brown, and Deborah M Stephens
Pemigatinib for Previously Treated Metastatic or Unresectable Central Nervous System Tumors with FGFR Mutations or Rearrangements: FIGHT-207 Results., Iben Spanggaard, Marc Matrana, Caio Rocha Lima, Amit Mahipal, Maria Vieito, Alice Hervieu, Lipika Goyal, Jordi Rodón, Maria Luisa Veronese, Natalia Oliveira, Xin Li, Michael Schaffer, and Santosh Kesari
Adjuvant chemotherapy for stage IA-IIA non-squamous, non-small-cell lung cancer identified as molecular high-risk by a 14-gene expression profile (AIM-HIGH): an international, randomised, phase 3 trial., David R Spigel, Virginie Westeel, Ian C Anderson, Laurent Greillier, Florian Guisier, Olivier Bylicki, Firas B Badin, Gaelle Rousseau-Bussac, Clotilde Deldycke, Frank Griesinger, Adam Bograd, Wangjian Zhong, Jacques Le Treut, Sylvie Van Hulst, David R Gandara, Martin Reck, Petra Hoffknecht, Matthew A Gubens, John Crowley, Heiko von der Leyen, Gavitt A Woodard, David M Jablons, Johannes R Kratz, Michael J Mann, and AIM-HIGH investigators
SITC strategic vision: prevention, premalignant immunity, host and environmental factors., Sasha E Stanton, Kristin G Anderson, Tullia C Bruno, Christian M Capitini, Mary L Disis, Jennifer McQuade, Laszlo Radvanyi, Claire Vanpouille-Box, Jennifer Wargo, Kelly J Baines, Megan M Y Hong, Adnan Rajeh, Raymond H Kim, Phillip Awadalla, Lauren K Hughes, and Saman Maleki Vareki
Phase 2 trial of imprime and pembrolizumab immunotherapy in metastatic triple negative breast cancer patients who have progressed beyond first line chemotherapy., Alison T Stopeck, Maysa Abu-Khalaf, Virginia Borges, Bartosz Chmielowski, Ruta Rao, Bin Xie, Arkadiusz Z Dudek, Lida Mina, Joyce O'Shaughnessy, Michael Chisamore, Paulette Mattson, Michele Gargano, Joanna Cox, Bruno Osterwalder, Jeremy Drees, Ben Harrison, Anissa S H Chan, Xiaohong Qiu, Nadine Ottoson, Nandita Bose, Mark Uhlik, Jeremy Graff, and Jose Iglesias
Concerted changes in Epithelium and Stroma: a multi-scale, multi-omics analysis of progression from Barrett's Esophagus to adenocarcinoma., Michael K Strasser, David L Gibbs, Philippe Gascard, Joanna Bons, John W Hickey, Deng Pan, Joseph A Caruso, Xianhong Wang, Chira Chen-Tanyolac, Rosemary Bai, Christian M Schürch, Yuqi Tan, Sarah Black, Pauline Chu, Alican Ozkan, Nathan Basisty, Veena Sangwan, Jacob Rose, Samah Shah, Jordan B Burton, Sophie Camilleri-Broet, Pierre Olivier Fiset, Nicholas Bertos, Julie Berube, Haig Djambazian, Rui Li, Spyridon Oikonomopoulos, Daffolyn Rachael Fels Elliott, Sarah Vernovsky, Elee Shimshoni, Deborah Collyar, Ann Russell, Jiannis Ragoussis, Matthew D Stachler, James R Goldenring, Stuart A C McDonald, Donald E Ingber, Birgit Schilling, Garry P Nolan, Thea D Tlsty, Sui Huang, and Lorenzo E Ferri
Off-the-shelf induced pluripotent stem-cell-derived natural killer-cell therapy in relapsed or refractory B-cell lymphoma: a multicentre, open-label, phase 1 study., Paolo Strati, Januario Castro, Aaron Goodman, Veronika Bachanova, Manali Kamdar, Farrukh T Awan, Scott R Solomon, Lilly Wong, Carol Wong, Deepa Patel, Cara Bickers, Wei Zhao, Zahid Bashir, Bahram Valamehr, Rebecca L Elstrom, and Krish Patel
SITC vision: Opportunities for deeper understanding of mechanisms of anti-tumor activity, toxicity, and resistance to optimize cancer immunotherapy., Ryan J Sullivan, Anthony R Cillo, Robert L Ferris, Russell W Jenkins, Harriet M Kluger, Marleen Kok, Evan J Lipson, Luca Paruzzo, William L Redmond, Marco Ruella, Kurt A Schalper, Daniela S Thommen, Keith Tolley, Mark Yarchoan, and Charlie Garnett-Benson
DRUG AND SINGLE-CELL GENE EXPRESSION INTEGRATION IDENTIFIES SENSITIVE AND RESISTANT GLIOBLASTOMA CELL POPULATIONS., Robert K Suter, Anna M Jermakowicz, Rithvik Veeramachaneni, Matthew D'Antuono, Longwei Zhang, Rishika Chowdary, Simon Kaeppeli, Madison Sharp, Pravallika Palwai, Vasileios Stathias, Grace Baker, Luz Ruiz, Winston Walters, Maria Cepero, Danielle Burgenske, Edward B Reilly, Anatol Oleksijew, Mark G Anderson, Sion Ll Williams, Michael E Ivan, Ricardo J Komotar, Macarena I De La Fuente, Gregory Stein, Alexander Wojcinski, Santosh Kesari, Jann N Sarkaria, Stephan C Schürer, and Nagi G Ayad
A Microfluidic, Multi-Antibody Cell Capture Method to Evaluate Tumor Cells in Cerebrospinal Fluid in Patients With Suspected Leptomeningeal Metastases., Nathan T Sweed, Hao-Ching Hsiao, Barbara Blouw, Tony J Pircher, Deanna Fisher, Katrina Rose Naluz, Julie Ann Mayer, Michael C Dugan, Akanksha Sharma, Jose Carrillo, and Santosh Kesari
Updates on radiotherapy-immunotherapy combinations: Proceedings of 8th Annual ImmunoRad Conference., Fereshteh Talebi, Fabiana Gregucci, Jalal Ahmed, Nir Ben Chetrit, Brian D Brown, Timothy A Chan, Dhan Chand, Julie Constanzo, Sandra Demaria, Dmitry I Gabrilovich, Encouse Golden, Andrew Godkin, Chandan Guha, Gaorav P Gupta, Aisha Hasan, Fernanda G Herrera, Howard Kaufman, Donna Li, Alan A Melcher, Sierra McDonald, Taha Merghoub, Arta M Monjazeb, Sébastien Paris, Sean Pitroda, Anguraj Sadanandam, Dörthe Schaue, Laura Santambrogio, Phillippe Szapary, Julien Sage, James W Welsh, Anna Wilkins, Kristina H Young, Eric Wennerberg, Laurence Zitvogel, Lorenzo Galluzzi, Eric Deutsch, and Silvia C Formenti
Development of a Diagnostic Model for Pancreatic Ductal Adenocarcinoma Using Machine Learning and Blood-Based miRNAs., Jason Y Tang, Valentina L Kouznetsova, Santosh Kesari, and Igor F Tsigelny
Intratumoral delivery of PD-1/PD-L1 and CTLA-4 inhibitors for recurrent/refractory solid tumors: a proof-of-concept treatment strategy., Hongye Tan, Noor Ul Huda Shah, Bingjia He, Tianrun Liu, Tianheng Li, Manting Liu, Yingying Gu, Cheng Zhi, Yongqiong Ou, Junhao Huang, Ming Li, Shenghua Zuo, Dongni Chen, Ruzhai Qin, Hainan Yang, Xufeng Li, Hui Lian, Qingde Wu, Rom Leidner, Rui Chen, Ankui Yang, Lili Yang, and Zhenfeng Zhang
Current landscape and future prospects of interleukin-2 receptor (IL-2R) agonists in cancer immunotherapy., Kengo Tanigawa and William L Redmond
Does paired genetic testing improve targeted therapy choices and screening recommendations for patients with upper gastrointestinal cancers and their families? A prospective cohort of 42 patients., Kevin Tatunay, Stacey Cohen, Lorraine V Naylor, Cynthia L Handford, Angela Jacobson, Veena Shankaran, Brant Oelschlager, William M Grady, Britta Sjoding, Everett Lally, Lauren Facchini, Qin Sun, Mercy Y Laurino, Colin Pritchard, Eric Q Konnick, and Marianne E Dubard-Gault
Society for Immunotherapy of Cancer: updates and best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) image analysis and data sharing., Janis M Taube, Joel C Sunshine, Michael Angelo, Guray Akturk, Margaret Eminizer, Logan L Engle, Cláudia S Ferreira, Sacha Gnjatic, Benjamin Green, Shirley Greenbaum, Noah F Greenwald, Cyrus V Hedvat, Travis J Hollmann, Daniel Jiménez-Sánchez, Konstanty Korski, Ana Lako, Edwin R Parra, Marlon C Rebelatto, David L Rimm, Scott J Rodig, Jamie Rodriguez-Canales, Jeffrey S Roskes, Kurt A Schalper, Emanuel Schenck, Keith E Steele, Michael J Surace, Alexander S Szalay, Michael T Tetzlaff, Ignacio I Wistuba, Jennifer H Yearley, and Carlo Bifulco
OVATION-2: A randomized phase I/II study evaluating the safety and efficacy of IMNN-001 (IL-12 gene therapy) with neo/adjuvant chemotherapy in patients newly-diagnosed with advanced epithelial ovarian cancer., Premal H Thaker, Debra L Richardson, Andrea R Hagemann, Robert W Holloway, Mark Reed, Melanie K Bergman, Bhavana Pothuri, Stephen DePasquale, Jennifer M Scalici, Amy J Bregar, Christopher J Darus, Karen Finkelstein, Charles A Leath, Maria Bell, David P Warshal, Richy Agajanian, Megan D Indermaur, Alberto A Mendivil, Diane M Provencher, Lee-Jen Wei, Nicholas Borys, Lauren Musso, Stacy R Lindborg, Douglas V Faller, Khursheed Anwer, and William H Bradley
Corrigendum to "OVATION-2: A randomized phase I/II study evaluating the safety and efficacy of IMNN-001 (IL-12 gene therapy) with neo/adjuvant chemotherapy in patients newly-diagnosed with advanced epithelial ovarian cancer" [Gynecol Oncol 2025 Jun 197 182-191]., Premal H Thaker, Debra L Richardson, Andrea R Hagemann, Robert W Holloway, Mark Reed, Melanie Bergman, Bhavana Pothuri, Stephen DePasquale, Jennifer M Scalici, Amy J Bregar, Christopher Darus, Karen Finkelstein, Charles A Leath, Maria Bell, David P Warshal, Richy Agajanian, Megan D Indermaur, Alberto A Mendivil, Diane M Provencher, Lee-Jen Wei, Nicholas Borys, Lauren Musso, Stacy R Lindborg, Douglas V Faller, Khursheed Anwer, and William H Bradley
Outcomes of CD19 CAR T in Transformed Indolent Lymphoma Compared to De Novo Aggressive Large B-Cell Lymphoma., Swetha Kambhampati Thiruvengadam, Reid Merryman, Yan Wang, Charles Gaulin, Evandro Bezerra, Timothy Voorhees, Madhav R Seshadri, Ayo Falade, Alma Habib, Amy A Ayers, Megumi Bailey, Annette Brown, Neil Bailey, Krish Patel, Charalambos B Andreadis, Adam S Kittai, Caron Jacobson, Joycelynne Palmer, Stephen J Forman, Loretta Nastoupil, and Lihua E Budde
Abemaciclib in combination with therapies for patients with metastatic breast cancer: a phase 1b study., Sara M Tolaney, Komal Jhaveri, Teresa Helsten, Shannon L Puhalla, Alison Conlin, E Claire Dees, Muralidhar Beeram, Sonya C Chapman, Andrew Lithio, Lacey M Litchfield, and Matthew P Goetz
Improving immunotherapy responses by dual inhibition of macrophage migration inhibitory factor and PD-1., Thuy T Tran, Gabriela Athziri Sánchez-Zuno, Lais Osmani, Jasmine Caulfield, Caroline Naomi Valdez, Marta Piecychna, Lin Leng, Michelle E Armstrong, Seamas C Donnelly, Carlo Bifulco, Terri Clister, Rajan P Kulkarni, Lin Zhang, Mario Sznol, Lucia Jilaveanu, Harriet M Kluger, Insoo Kang, and Richard Bucala
Characteristics of patients with liver tumors deemed ineligible for enrollment on Children's Oncology Group trial AHEP1531: An opportunity to expand inclusion criteria and improve outcome., Angela Trobaugh-Lotrario, Allison F O'Neill, Katelyn A Belmonte, Marcio H Malogolowkin, Greg M Tiao, and James I Geller
Multimodal AI generates virtual population for tumor microenvironment modeling., Jeya Maria Jose Valanarasu, Hanwen Xu, Naoto Usuyama, Chanwoo Kim, Cliff Wong, Peniel Argaw, Racheli Ben Shimol, Angela Crabtree, Kevin Matlock, Alexandra Q Bartlett, Jaspreet Bagga, Yu Gu, Sheng Zhang, Tristan Naumann, Bernard A Fox, Bill J. Wright, Ari Robicsek, Brian D. Piening, Carlo Bifulco, Sheng Wang, and Hoifung Poon
Effect of HLA restriction on racial and ethnic disparities in access to immune therapies for advanced synovial sarcoma., Vinayak Venkataraman, Hannah R Abrams, David S Shulman, Elizabeth T Loggers, Seth M Pollack, Kelly G Paulson, and Michael J Wagner
Molecular Correlates of Long-Term Response to Bevacizumab in Glioblastoma., John L Villano, Catherine R Garcia, Rachael M Morgan, Shulin Zhang, Jill Kolesar, Farhan A Mirza, Timothy Samec, Joanne Xiu, Stephanie Rock, Santosh Kesari, Emil Lou, Sonikpreet Aulakh, Michael J Glantz, and Eric T Wong
Outcomes in patients with classic Hodgkin lymphoma refractory or intolerant to brentuximab vedotin and anti-PD-1 therapy: a real world analysis from 15 U.S. academic centers., Timothy J Voorhees, Eric M McLaughlin, Pallawi Torka, Jorge Florindez, Na Hyun Kim, Tamara K Moyo, Heather Reves, Nuttavut Sumransub, Saarang Deshpande, Ashley Rose, Cassandra Duarte, Muhammad Salman Faisal, Showkat Hamid, Suki Subbiah, Sabarish Ayyappan, Lauren Shea, Matt Cortese, Krish Patel, Ajay Major, Hayder Saeed, Jakub Svoboda, Sanjal Desai, Praveen Ramakrishnan Geethakumari, Mehdi Hamadani, Natalie Grover, and Narendranath Epperla
Editorial Expression of Concern: Safety of targeting tumor endothelial cell antigens., Samuel C Wagner, Neil H Riordan, Thomas E Ichim, Julia Szymanski, Hong Ma, Jesus A Perez, Javier Lopez, Juan J Plata-Munoz, Francisco Silva, Amit N Patel, and Santosh Kesari
Developing a novel medulloblastoma diagnostic with miRNA biomarkers and machine learning., Chloe Wang, Valentina L Kouznetsova, Santosh Kesari, and Igor F Tsigelny
Onycholemmal Carcinoma Excised by Mohs Micrographic Surgery With Immediate Frozen Section Bone Examination., Jiasen Wang, Sagar Patel, Steven E Kolker, and Richard G Bennett
